1. Abbasi F, Kamath V, Rizvi AA, Carantoni M, Chen YD, Reaven GM (1997) Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue. Diabetes Care 20:1863–69.
2. Bailey CJ (1999) Insulin resistance and antidiabetic drugs. Biochem Pharmacol 58:1511–20.
3. Bailey CJ, Turner RC (1996) Metformin N Engl J Med 334:574–9.
4. Beisswenger PJ, Howell SK, Touchette AD, Lal S, Szwergold BS (1999) Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes 48:198–202.
5. Campbell IW and Howlett HC (1995) Worldwide experience of metformin as an effective glucose-lowering agent: a meta-analysis. Diabetes Metab Rev 11 Suppl 1:857–62.